PER percheron therapeutics limited

EQUITY RESEARCH REPORT - WILSON dated 18 Jan 2022, page-112

  1. 169 Posts.
    lightbulb Created with Sketch. 163
    I have to say that holding this stock has been exciting but the quietness on the shortfall of capital raised is such a big question mark for this stock.

    l know many have got lots of issues with the last raising but I think the capital raising and the intention is probably not the worst part. In fact I thought the design and the options were a sort of compromise (albeit not a great one).

    What is quite hard to swallow however is the lack of communication after the shortfall. Integrity and transparency of management is what I'm looking for. AND they should have had a backup plan. Had hoped this issue would be addressed in the Quarterly.

    Please do let me know if I've missed anything.

    Last edited by CrispyPork777: 01/02/22
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.8¢
Change
-0.001(5.88%)
Mkt cap ! $8.699M
Open High Low Value Volume
0.9¢ 0.9¢ 0.8¢ $16.64K 2.010M

Buyers (Bids)

No. Vol. Price($)
24 6525662 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1987416 4
View Market Depth
Last trade - 15.25pm 18/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.